Anlotinib plus camrelizumab and chemotherapy as first-line treatment in patients with advanced esophageal squamous cell carcinoma

M Mingfang Xu Y Yu Pu Y Yuzhu Jiang Y Yingda Liu Y Yan Feng X Xiaodong Zhao M Mengxia Li

Article Details

Volume / Issue Vol. 15, Issue 1
Published July 01, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (7)

M

Mingfang Xu

Y

Yu Pu

Y

Yuzhu Jiang

Y

Yingda Liu

Y

Yan Feng

X

Xiaodong Zhao

M

Mengxia Li